By studying a panel of 40 HCC cell lines and 30 HCC patient-derived xenograft models, the expression levels of FGF19 are implicated as a predictive biomarker for H3B-6527 response [64]. This evidence concerns the gene FGF19 and hepatocellular carcinoma.